UK markets closed
NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.56 +0.08 (+0.10%) GOLD FUTURES
2,322.20 -9.00 (-0.39%) DOW
38,862.70 +10.43 (+0.03%) Bitcoin GBP
50,476.32 -247.37 (-0.49%)
Axsome Therapeutics, Inc. (AXSM)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 02:50PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.61B |
| Enterprise value | 3.46B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 14.03 |
| Price/book (mrq) | 25.04 |
| Enterprise value/revenue | 12.80 |
| Enterprise value/EBITDA | -15.40 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.10 |
| 52-week change 3 | -1.04% |
| S&P500 52-week change 3 | 25.77% |
| 52-week high 3 | 98.40 |
| 52-week low 3 | 55.02 |
| 50-day moving average 3 | 74.33 |
| 200-day moving average 3 | 74.80 |
Share statistics
| Avg vol (3-month) 3 | 733.74k |
| Avg vol (10-day) 3 | 547.84k |
| Shares outstanding 5 | 47.49M |
| Implied shares outstanding 6 | 47.49M |
| Float 8 | 34.97M |
| % held by insiders 1 | 17.04% |
| % held by institutions 1 | 83.67% |
| Shares short (15 Apr 2024) 4 | 7.75M |
| Short ratio (15 Apr 2024) 4 | 11.26 |
| Short % of float (15 Apr 2024) 4 | 19.62% |
| Short % of shares outstanding (15 Apr 2024) 4 | 16.32% |
| Shares short (prior month 15 Mar 2024) 4 | 7.3M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -118.07% |
| Operating margin (ttm) | -91.58% |
Management effectiveness
| Return on assets (ttm) | -32.76% |
| Return on equity (ttm) | -231.68% |
Income statement
| Revenue (ttm) | 251.02M |
| Revenue per share (ttm) | 5.41 |
| Quarterly revenue growth (yoy) | -20.70% |
| Gross profit (ttm) | N/A |
| EBITDA | -246.15M |
| Net income avi to common (ttm) | -296.38M |
| Diluted EPS (ttm) | -6.45 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 331.44M |
| Total cash per share (mrq) | 6.98 |
| Total debt (mrq) | 188.8M |
| Total debt/equity (mrq) | 131.08% |
| Current ratio (mrq) | 3.20 |
| Book value per share (mrq) | 3.04 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.